v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses:        
Research and development $ 18,607 $ 14,329 $ 39,532 $ 25,776
General and administrative 10,946 1,744 19,883 3,212
Total operating expenses 29,553 16,073 59,415 28,988
Loss from operations (29,553) (16,073) (59,415) (28,988)
Other income:        
Interest income 4,838 103 7,319 585
Other income 1,213 325 1,362 358
Total other income, net 6,051 428 8,681 943
Loss before income taxes (23,502) (15,645) (50,734) (28,045)
Income tax benefit 0 0 0 0
Net loss (23,502) (15,645) (50,734) (28,045)
Net loss attributable to common stock, basic (23,502) (18,014) (53,513) (32,596)
Net loss attributable to common stock, diluted $ (23,502) $ (18,014) $ (53,513) $ (32,596)
Net loss per share of common stock, basic (in usd per share) $ (0.58) $ (24.19) $ (1.69) $ (44.00)
Net loss per share of common stock, diluted (in usd per share) $ (0.58) $ (24.19) $ (1.69) $ (44.00)
Weighted average common stock outstanding, basic (in shares) 40,436,264 744,641 31,619,178 740,808
Weighted average common stock outstanding, diluted (in shares) 40,436,264 744,641 31,619,178 740,808
Other comprehensive loss:        
Net unrealized losses on marketable securities $ (371) $ (4) $ (955) $ (4)
Total other comprehensive loss (371) (4) (955) (4)
Total comprehensive loss $ (23,873) $ (15,649) $ (51,689) $ (28,049)